Mankind Pharma has announced that its board of directors will convene on September 24, 2024, to discuss and potentially approve a proposal to raise funds through the issuance of various securities. The company is considering multiple options, including non-convertible debentures, commercial papers, and other forms of debt securities, according to a regulatory filing.
Read More_20240903174817_original_image_27.webp)
PresVu is the first eye drop in India specifically designed to reduce the dependency on reading glasses for people with presbyopia.
Read More
By replicating normal physiological processes, the Micro Dose System (MDS) significantly reduces insulin resistance, enhancing the absorption of blood sugar into cells and its conversion into energy
Read More
With a rich history of utilisation in traditional medicine spanning centuries, adaptogens are experiencing a resurgence in modern times, propelled by a growing enthusiasm for alternative health approaches
Read More
